Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Tugba Gul Inci

2PUBLICATIONS

8CO-AUTHORS

NanomedicineBiomolecular modelling and design

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Jul 25, 2024

Nonsmall-cell lung cancer treatment: current status of drug repurposing and nanoparticle-based drug delivery systems.

Tuğba Gül Inci, Serap Acar, Dilek Turgut-Balik

|Sep 16, 2020

Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: an <i>in silico</i> structure-based approach.

Ozal Mutlu, Osman Mutluhan Ugurel, Emrah Sariyer

Pageof 1

Frequent Collaborators

2 joint publications

Dilek Turgut-Balik

1 joint publications

Ozal Mutlu

1 joint publications

Osman Mutluhan Ugurel

1 joint publications

Emrah Sariyer

1 joint publications

Oguz Ata

1 joint publications

Erennur Ugurel

1 joint publications

Sinem Kocer

1 joint publications

Serap Acar

Frequent Collaborators

2 joint publications

Dilek Turgut-Balik

1 joint publications

Ozal Mutlu

1 joint publications

Osman Mutluhan Ugurel

1 joint publications

Emrah Sariyer

Top Related Videos

A Comprehensive Procedure to Evaluate the <em>In Vivo</em> Performance of Cancer Nanomedicines

A Comprehensive Procedure to Evaluate the <em>In Vivo</em> Performance of Cancer Nanomedicines

Published on : Mar 04, 2017

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on : Sep 26, 2025

See more related videos

Top Related Videos

A Comprehensive Procedure to Evaluate the <em>In Vivo</em> Performance of Cancer Nanomedicines

A Comprehensive Procedure to Evaluate the <em>In Vivo</em> Performance of Cancer Nanomedicines

Published on : Mar 04, 2017

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on : Sep 26, 2025

See more related videos